Xarelto, Pradaxa, and all Blood Thinner Cases
Xarelto was initially approved in 2011 and is one of the most recent blood thinners on the market. The blood thinner is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals.
Dangerous side effects include:
- Internal bleeding
- Intestinal bleeding
- Rectal bleeding
- Blood clots
- Brain hemorrhaging
- Death caused by uncontrolled bleeding
Multidistrict Litigation (MDL) against Xarelto Manufacturer
Bayer and Johnson & Johnson Seek Further Federal Approvals for Xarelto
According to an article posted on Drug Watch on February 17th, 2015 filed under Current Litigation & Lawsuit News, the announcement was made that Bayer and J&J are seeking further federal approvals for Xarelto for stroke patients, even as cases are consolidated into MDL.
Xarelto Bellwether Trials Set to Take Place in 2017
The court has started the process of selecting 40 cases for the Xarelto multidistrict litigation bellwether trial pool. The Xarelto MDL is underway is the U.S. District Court in the Eastern District of Louisiana. Four bellwether trials are set to begin in February of 2017. The first two trials are set to take place in the Eastern District of Louisiana on February 6th, 2017 and March 13th, 2017. The third and fourth trials will take place in Mississippi and Texas on April 24th, 2017 and May 30th, 2017.
Pradaxa and FDA Reports
Pradaxa is a blood thinner medication that was approved by the U.S. Food & Drug Administration (FDA) in 2010 to reduce the risk of strokes and pulmonary embolism in those who suffer from non-valvular atrial fibrillation. Pradaxa was originally marketed to replace warfarin as a better alternative. However, by 2011, its first year after entering the market, the Boehringer-Ingelheim manufactured drug was linked to more than 500 deaths in the U.S. and was named in 932 adverse event reports by the end of 2011.
2012 – According to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices, he indicated that the FDA data since 2010 has revealed 1,158 U.S. deaths and 12,494 serious injuries linked to Pradaxa – more complaints than any other U.S. drug.
2013 – FDA announces a new, large-scale assessment of Pradaxa bleeding rates in relation to warfarin.
Dangerous side effects of Pradaxa include:
- Death by Severe Bleeding
- Hospital Stays Due to Severe Bleeding
- Large Bruises, unexplainable bruises
- Coughing up Blood Clots
- Menstrual or Vaginal Bleeding that is Heavier than Normal
Pradaxa Settlement Reached for 4K Active Cases
According to the settlement terms, the average settlement amount for each case is $162K, although many cases with serious injuries, including death, reached figures of approximately $500K.
How Legal-Bay Can Help You
If you have retained a law firm on behalf of yourself (or a family member) regarding any of the above injuries from Xarelto or Pradaxa and cannot wait for your settlement check any longer, Legal-Bay can help you by giving you a lawsuit settlement funding cash advance so that you can pay bills and live your life with dignity until you receive your ultimate settlement check.
Legal-Bay offers the fastest approvals in the industry and the lowest rates on most Xarelto and Pradaxa cases. If you apply today, you could have cash in just 48 hours!
All you need to do is fill out the application on the upper left side of this page and an experienced funding agent will call you promptly. Or, if you prefer to speak to a live person right now, you can call Legal-Bay’s toll-free hotline at: 866.792.0234
If you are unsure if you have a potential lawsuit claim against either of the manufacturers and need a free case evaluation from a Xarelto or Pradaxa law firm or lawyer, feel free to contact Legal-Bay right now.